Mestriner FMAM, Benitez MLF, Müeller A, Lima CCA, Gama S, Maria GS, Silveira D

Language: English
References: 21
Page: 216-223
PDF size: 42.45 Kb.

ABSTRACT

Introduction: Tabernaemontana solanifolia A. DC. (Apocynaceae) grows in the Cerrado (savanna), Caatinga (shrublands), and Atlantic Forest of Brazil.
Objective: to investigate the potential anxiolytic activity of the crude extracts and ß-amyrin acetate obtained from the leaves of Tabernaemontana solanifolia in the elevated plus-maze (EPM) test for anxiety in rats.
Methods: the crude extracts (aqueous, ethanol, and hexane), as well as ß-amyrin acetate, obtained from Tabernaemontana solanifolia leaves were evaluated for possible anxiolytic effects in rats tested in the elevated plus-maze. Acute toxicity in rats was determined by OECD 423 guidelines. The leaves of T. solanifolia specimens collected in Brasília, Brazil, were air dried at 40 °C and macerated with hexane or ethanol. After filtration, the solvents were removed under reduced pressure, yielding the crude hexane and ethanolic extracts (5.96 and 18.62 % yield, respectively). The crude aqueous extract was obtained by infusion, followed by lyophilization (13.5 % yield). Thirty minutes before the elevated plus-maze experiments, the animals were treated with the crude ethanol extract (1 000 mg/kg of body weight [bw], p.o.), the crude hexane extract (1 000 mg/kg bw, p.o.), the crude extract (1 000 mg/kg bw, p.o.), or ß-amyrin acetate (21 mg/kg bw, p.o.).
Results: the extracts cauded no mortality up to 2 000 mg/kg, so half of DL50 doses were selected for the present study. The crude extracts (hexane, ethanolic and aqueous) (1.0 g/kg) as well as the substance ß-amyrin acetate (21 mg/kg) were administered once, increasing the number of entries into and the time spent in the closed arms of the elevated plus-maze.
Conclusion: the oral administration of the extracts and ß-amyrin acetate obtained from Tabernaemontana solanifolia had an anxiogenic effect in rats. Further studies are needed in order to identify and characterize the anxiogenic properties of Tabernaemontana solanifolia and to understand the anxiogenic mechanisms of the extracts.

REFERENCES

1. Van Beek TA, Verpoorte R, Baerheim Svendsen A, Leeuwenberg AJM, Bisset NG. Tabernaemontana L. (Apocynaceae). A review of its taxonomy, phytochemistry, ethnobotany and pharmacology. J Ethnopharmacol. 1984;10(1):1-156.

2. Rapini A, Koch I, Kinoshita, LS, Simões AO, Spina AP. Apocynaceae in Lista de Espécies da Flora do Brasil. Jardim Botânico do Rio de Janeiro. Available at: http://floradobrasil.jbrj.gov.br/2010/FB004866

3. Gower AE, Pereira BDS, Marsaioli AJ. Indole alkaloids from Peschiera campestris. Phytochemistry. 1986;25(12):2908-10.

4. Leeuwenberg AJM: A revision of Tabernaemontana 1. The old World species. Kew, United Kingdom; 1991. p. 223.

5. Leeuwenberg AJM: A revision of Tabernaemontana. The new World Species and Stemmadenia. Vol. 2. Kew, United Kingdom: Royal Botanical Gardens Press; 1994. p. 450.

6. Rodrigues E, Carlini EL, Araujo L. Plants with possible psychoactive actions used by the Krahô Indian, Brazil. Rev Bras Psiquiatr. 2006;28(4):277-82.

7. Basavaraj P, Shivakumar B, Shivakumar H. Anxiolytic activity of Tabernaemontana divaricata (Linn) R. Br. Flowers extract in mice. J Pharma Bio Sciences. 2011;2(3):65-72.

8. Montgomery KC. The relation between fear induced by novel stimulation and exploratory behavior. J Comp Physiol Psychol. 1955;48(4):254-60.

9. Pellow S, Chopin P, File SE, Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods. 1985;14(3):149-67.

10. Carobrez AP, Bertoglio LJ. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev. 2005;29(8):1193-205.

11. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav. 1996;54(1):21-30.

12. Organization of Economic Co-operation and Development (OECD). OECD guidelines on acute oral toxicity, environmental health and safety monograph series on testing and adjustment: 423 acute oral toxicity. Paris: OECD; 1996.

13. Melo AAMF, Gama SM, Macorini LFB, Nascimento C, Honorato CA, Vasconcelos PC, et al. Acute oral toxicity of extracts of Tabernaemontana solanifolia A. DC. (Apocynaceae). Lat Am J Pharm. 2012;31(8):1149-54.

14. Graeff FG, Ferreira Neto C, Zangrossi JH. The elevated T-maze as an experimental model of anxiety. Neurosci Behav Rev. 1998;23(2):237-46.

15. Cruz AP, Frei F, Graeff FG. Ethnopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol Biochem Behav. 1994; 49(1):171-6.

16. Walf AA, Frye CA. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc. 2007;2(2):322-8.

17. Handley SL, MacBlane JW. 5-HT drugs in animal models of anxiety. Psychopharmacol. 1993;112(1):13-20.

18. Lister RG. The use of a plus-maze to measure anxiety in the mouse. J Psychopharmacol. 1987;92(2):180-5.

19. Aragão GF, Carneiro LMV, Junior APF, Vieira LC, Lemos TLG, Viana GS de B. A possible mechanism for anxiolytic and antidepressant effects of alpha- and beta-amyrin from Protium heptaphyllum (Aubl.). Pharmacol Biochem Behav. 2006;85(4):827-34.

20. Rodgers RJ, Johnson NJT. Behaviorally selective effects of neuroactive steroids on plus-maze anxiety in mice. Pharmacol Biochem Behav. 1998;59(1):221-32.

21. Rauppa IM, Serenikia A, Virtuoso S, Ghislandi C, Cavalcanti Silva EL, Trebien HA, et al. Anxiolytic-like effect of chronic treatment with Erythrina velutina extract in the elevated plus-maze test. J Ethopharmacol. 2008;118(2):295-9.